{"id":3521,"date":"2022-02-22T00:00:00","date_gmt":"2022-02-21T17:00:00","guid":{"rendered":"https:\/\/www.hivnat.org\/en\/?p=3521"},"modified":"2022-04-04T09:13:50","modified_gmt":"2022-04-04T02:13:50","slug":"virtual-conference-on-retroviruses-and-opportunistic-infections-croi-held-on-february-22-24-2022","status":"publish","type":"post","link":"https:\/\/www.hivnat.org\/en\/presentations\/3521\/","title":{"rendered":"Virtual Conference on retroviruses and opportunistic infections (CROI) held on February 22-24, 2022"},"content":{"rendered":"\n<ol class=\"wp-block-list\"><li>Han WM, Apornpong T, Ubolyam S, Ker SJ, Avihingsanon A. <strong>Metabolic Associated Fatty Liver Disease and its Association with Epicardial Fat<\/strong> (Poster) <a href=\"https:\/\/www.croiconference.org\/abstract\/metabolic-associated-fatty-liver-disease-and-its-association-with-epicardial-fat\/\">https:\/\/www.croiconference.org\/abstract\/metabolic-associated-fatty-liver-disease-and-its-association-with-epicardial-fat\/<\/a><\/li><li>Han WM, Apornpong T, Gatechompol S, Ubolyam S, Kerr SJ, Erlandson K. <strong>Association of phenotypic aging with comorbidities, Farilty and Inflammatory Marker<\/strong>. (Poster) <a href=\"https:\/\/www.croiconference.org\/abstract\/association-of-phenotypic-aging-with-comorbidities-frailty-and-inflammatory-marker\/\">https:\/\/www.croiconference.org\/abstract\/association-of-phenotypic-aging-with-comorbidities-frailty-and-inflammatory-marker\/<\/a><\/li><li>Tan S, Thanprasertsuk S, Thongsawat S, Salvadori N, Menetrey C, STORM-C-1 Research Team. <strong>Efficacy &amp; Safety of Ravidasvir + Sofosbuvir in Hepatitis C: STROM-C-1 Final Results<\/strong>. (Poster) <a href=\"https:\/\/www.croiconference.org\/abstract\/efficacy-safety-of-ravidasvir-sofosbuvir-in-hepatitis-c-storm-c-1-final-results\/\">https:\/\/www.croiconference.org\/abstract\/efficacy-safety-of-ravidasvir-sofosbuvir-in-hepatitis-c-storm-c-1-final-results\/<\/a><\/li><li>Singh KP, Zerbato J, Zhao W, Wong DK, Cloherty G, Gersch J, Mason H, Rhodes A, Revill P, Avihingsanon A, Audsley J, Yuen M, Lewin S. <strong>Hepatitis B RNA and Core-related Antigen in HIV-HBV Coinfection<\/strong>. (poster) <a href=\"https:\/\/www.croiconference.org\/abstract\/hepatitis-b-rna-and-core-related-antigen-in-hiv-hbv-coinfection\/\">https:\/\/www.croiconference.org\/abstract\/hepatitis-b-rna-and-core-related-antigen-in-hiv-hbv-coinfection\/<\/a><\/li><li>Chattranukulchai P, Siwamogsatham S, Lwin HMS, Apornpong T, Han WM, Gatechompol S, Putcharoen O, Avihingsanon A. <strong>High-sensitive Troponins and Coronary Calcium Score in Older Asian HIV<\/strong>. (poster) <a href=\"https:\/\/www.croiconference.org\/abstract\/high-sensitive-troponins-and-coronary-calcium-score-in-older-asian-hiv\/\">https:\/\/www.croiconference.org\/abstract\/high-sensitive-troponins-and-coronary-calcium-score-in-older-asian-hiv\/<\/a><\/li><li>Janekrongtham C, Lolekha R, Avihingsanon A, Ariyothai N, Luengwattanapong R, Mookleemas P, Kittinunvorakoon C, Sethaputra C, Jirajariyavej S, Ubolyam S, Fujitnirun C, Watcharasuwanseree S, Ayuthaya TPN, Northbrook S, Lertpiriyasuwat C. <strong>Potential Use of Urine LF-LAM in Diagnosing Active TB in Thai HIV-Positive Adults<\/strong> (poster) <a href=\"https:\/\/www.croiconference.org\/abstract\/potential-use-of-urine-lf-lam-in-diagnosing-active-tb-in-thai-hiv-positive-adults\/\">https:\/\/www.croiconference.org\/abstract\/potential-use-of-urine-lf-lam-in-diagnosing-active-tb-in-thai-hiv-positive-adults\/<\/a><\/li><\/ol>\n\n\n\n<p><strong>A5324 study<\/strong><\/p>\n\n\n\n<p>Letendre SL, Roa J, Chen H, McKhann A, Marra CM, Daar ES, Hunt PW, Campbell T, Swaminathan S, Ha B, Alston-Smith B, Paul R, Spudich SS. <strong>ACTG A5324: A randomized trial of ART intensification for cognitive impairment in PWH<\/strong> (poster) <a href=\"https:\/\/www.natap.org\/2022\/CROI\/croi_187.htm\">https:\/\/www.natap.org\/2022\/CROI\/croi_187.htm<\/a><\/p>\n\n\n\n<p><strong>A5332 study<\/strong><\/p>\n\n\n\n<ol class=\"wp-block-list\"><li>Weir IR, Overton ET, Zanni MV, Fischinger S, Fitch K, Aberg JA, Fichtenbaum CJ, Bloomfield GS, Malvestutto C, McCallum S, Douglas PS, Alter G, Ribaudo HJ, Grinspoon S. <strong>Asymptomatic SARS-CoV-2 Infection is Extremely Common Among People with HIV<\/strong> (poster) <a href=\"https:\/\/www.croiconference.org\/abstract\/asymptomatic-sars-cov-2-infection-is-extremely-common-among-people-with-hiv\/\">https:\/\/www.croiconference.org\/abstract\/asymptomatic-sars-cov-2-infection-is-extremely-common-among-people-with-hiv\/<\/a><\/li><li>Erlandson K, Fitch K, McCallum S, Ribaudo HJ, Overton ET, Bloomfield GS, Brown T, Fichtenbaum CJ, Bares S, Aberg JA, Douglas PS, Moran L, Mave V, Grinspoon S. <strong>Geographical Differences in Functional Impairment of People with HIV<\/strong>. (oral presentation) <a href=\"https:\/\/ww2.aievolution.com\/cro2201\/index.cfm?do=abs.viewAbs&amp;abs=1148\">https:\/\/ww2.aievolution.com\/cro2201\/index.cfm?do=abs.viewAbs&amp;abs=1148<\/a><\/li><li>Fulda ES, Fitch K, Overton ET, Zanni MV, Aberg JA, Currier JS, Lu MT, Malvestutto C, Fichtenbaum CJ, Martinez E, Umbleja T, Douglas PS, Fibaudo HJ, Grinspoon S. <strong>COVID-19 Vaccination rates in a Global HIV Cohort<\/strong>. (oral presentation) <a href=\"https:\/\/academic.oup.com\/jid\/article\/225\/4\/603\/6431673\">https:\/\/academic.oup.com\/jid\/article\/225\/4\/603\/6431673<\/a><\/li><li>Fichtenbaum CJ, Ribaudo HJ, Taron J, Leon-Cruz JT, Utay NS, Ho K, Luetkemeyer A, Swaminathan S, Johnston C, Fulda ES, Kileel E, Lu MT, Grinspoon S, Lake J. <strong>NAFLD is Common and Associated with Cardiovascular Risk in REPRIEVE Participants<\/strong>. (poster) <a href=\"https:\/\/www.croiconference.org\/abstract\/nafld-is-common-and-associated-with-cardiovascular-risk-in-reprieve-participants\/\">https:\/\/www.croiconference.org\/abstract\/nafld-is-common-and-associated-with-cardiovascular-risk-in-reprieve-participants\/<\/a><\/li><li>Zanni MV, Foldyna B, Williams K, Burdo TH, McCallum S, Looby SE, Autissier P, Fitch K, Currier JS, Lu MT, Douglas PS, Ribaudo HJ, Grinspoon S. <strong>Subclinical Atherosclerosis and Immune Activation Among US Females Vs Males with HIV<\/strong>. (poster) <a href=\"https:\/\/www.croiconference.org\/abstract\/subclinical-atherosclerosis-and-immune-activation-among-us-females-vs-males-with-hiv\/\">https:\/\/www.croiconference.org\/abstract\/subclinical-atherosclerosis-and-immune-activation-among-us-females-vs-males-with-hiv\/<\/a><\/li><li>Overton ET, Kantor A, Fitch K, Muntner PM, Mosepele M, Aberg JA, Fichtenbaum CJ, McComsey GA, Malvestutto C, Lu MT, Doublas PS, Grinspoon S, Ribaudo HJ, Wyatt C. <strong>Proteinuria is Common Among People with HIV with Controlled HIV Viremia<\/strong>. (poster) <a href=\"https:\/\/www.croiconference.org\/abstract\/proteinuria-is-common-among-people-with-hiv-with-controlled-hiv-viremia\/\">https:\/\/www.croiconference.org\/abstract\/proteinuria-is-common-among-people-with-hiv-with-controlled-hiv-viremia\/<\/a><\/li><\/ol>\n\n\n\n<p><strong>A5345 study<\/strong><\/p>\n\n\n\n<p>Li J, Kittilson A, Melbergh M, Wonderlich ER, Kinslow J, Aga E, Bosch RJ, Coombs R, Deeks SG, Gandhi RT, Busch MP, Landay A, Macatangay BJ, Smith DM. <strong>Size and Activity of the HIV Reservoir Predict Rebound Timing after ART Interruption<\/strong>. (Poster) <a href=\"https:\/\/www.croiconference.org\/abstract\/size-and-activity-of-the-hiv-reservoir-predict-rebound-timing-after-art-interruption\/\">https:\/\/www.croiconference.org\/abstract\/size-and-activity-of-the-hiv-reservoir-predict-rebound-timing-after-art-interruption\/<\/a><\/p>\n\n\n\n<p><strong>A5354 study<\/strong><\/p>\n\n\n\n<ol class=\"wp-block-list\"><li>Daar ES, Ritz J, Zheng L, Ananworanich J, Kanyama C, Little SJ, Cohn SE, Riddler SA, Collier AC, Coombs R, Fox L, Lama JR, Crowell TA. <strong>Feasibility and Viral Response to Treating Acute\/Early HIV in a Multinational Study<\/strong>. (Poster) <a href=\"https:\/\/www.croiconference.org\/abstract\/feasibility-and-viral-response-to-treating-acute-early-hiv-in-a-multinational-study\/\">https:\/\/www.croiconference.org\/abstract\/feasibility-and-viral-response-to-treating-acute-early-hiv-in-a-multinational-study\/<\/a><\/li><li>Sieg SF, Puleo JA, Zheng L, Clagett B, Lama JR, Fox L, Ananworanich J, Ruxrungtham K, Grinszteign B, Arduino RC, Eron JJ, Mellors JW, Daar ES, Crowell TA. <strong>HIV-Specific T-Cell Frequencies and Function After ART During Acute or Early HIV<\/strong>. (Poster) <a href=\"https:\/\/www.croiconference.org\/abstract\/hiv-specific-t-cell-frequencies-and-function-after-art-during-acute-or-early-hiv\/\">https:\/\/www.croiconference.org\/abstract\/hiv-specific-t-cell-frequencies-and-function-after-art-during-acute-or-early-hiv\/<\/a><\/li><li>Veen LV, Moldt B, Selzer L, Li J, Parvangada PC, Ananworanich J, Crowell TA, Eron JJ, Daar ES, Haubrich RH, Geleziunas R, Cyktor J, Mellors JW, Callebaut C. <strong>HIV Envelope Diversity and Sensivity to bNAbs Across Stages of Acute and Early HIV<\/strong>. (Poster) <a href=\"https:\/\/www.croiconference.org\/abstract\/hiv-envelope-diversity-and-sensitivity-to-bnabs-across-stages-of-acute-and-early-hiv\/\">https:\/\/www.croiconference.org\/abstract\/hiv-envelope-diversity-and-sensitivity-to-bnabs-across-stages-of-acute-and-early-hiv\/<\/a><\/li><li>Crowell TA, Ritz J, Zheng L, Naqvi A, Cyktor J, Sieg SF, Lama JR, Rooney JF, Fox L, Ananworanich J, Eron JJ, Zyl GV, Mellors JW, Daar ES. <strong>Early antiretroviral therapy reduces but does not eliminate HIV DNA in blood<\/strong>. (Poster) <a href=\"https:\/\/www.croiconference.org\/abstract\/early-antiretroviral-therapy-reduces-but-does-not-eliminate-hiv-dna-in-blood\/\">https:\/\/www.croiconference.org\/abstract\/early-antiretroviral-therapy-reduces-but-does-not-eliminate-hiv-dna-in-blood\/<\/a><\/li><\/ol>\n\n\n\n<p><strong>A5360 study<\/strong><\/p>\n\n\n\n<p>Sowah L, Smeaton LM, Brates I, Bhattacharya D, Linas B, Kreter B, Wagner-Cardoso S, Solomon SS, Sulkowski MS, Robbins GK. <strong>Adherence in the ACTG A5360 HCV Minimal Monitoring (MINMON) Trial<\/strong>.(poster) <a href=\"https:\/\/www.croiconference.org\/abstract\/adherence-in-the-actg-a5360-hcv-minimal-monitoring-minmon-trial\/\">https:\/\/www.croiconference.org\/abstract\/adherence-in-the-actg-a5360-hcv-minimal-monitoring-minmon-trial\/<\/a><\/p>\n\n\n\n<p><strong>A5372 study<\/strong><\/p>\n\n\n\n<p>Imperial MZ, Luetkemeyer A, Dawson R, Cramer Y, Rosenkranz S, Swindells S, Gelmanova I, Avihingsanon A, Arduino RC, Samaneka W, Dooley K, Savic R, Podany AT. <strong>DTG PK in people with HIV receiving daily 1HP for latent TB treatment<\/strong>. (oral presentation) <a href=\"https:\/\/www.natap.org\/2022\/CROI\/croi_102.htm\">https:\/\/www.natap.org\/2022\/CROI\/croi_102.htm<\/a><\/p>\n\n\n\n<p><strong>A5375 study<\/strong><\/p>\n\n\n\n<p>Mngqibisa R, Smeaton LM, Olefsky M, Podany AT, Barr E, Belaunzaran P, Badal-Faesen S, Kachale E, Kanyama C, Schalkwyk MV, Woolley E, Cohn SE, Godfrey C, Scarsi KK. <strong>PK of dose-adjusted emergency contraception with rifampicin therapy in ACTG A5375<\/strong>. (oral presentation) <a href=\"https:\/\/ww2.aievolution.com\/cro2201\/index.cfm?do=abs.viewAbs&amp;abs=1452\">https:\/\/ww2.aievolution.com\/cro2201\/index.cfm?do=abs.viewAbs&amp;abs=1452<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Han WM, Apornpong T, Ubolyam S, Ker SJ, Avihingsanon A. Metabolic Associated Fatty Liver Disease and its Association with Epicardial Fat (Poster) https:\/\/www.croiconference.org\/abstract\/metabolic-associated-fatty-liver-disease-and-its-association-with-epicardial-fat\/ Han WM, Apornpong T, Gatechompol S, Ubolyam&hellip; <\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[66],"tags":[],"class_list":["post-3521","post","type-post","status-publish","format-standard","hentry","category-presentations"],"_links":{"self":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/3521","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/comments?post=3521"}],"version-history":[{"count":14,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/3521\/revisions"}],"predecessor-version":[{"id":3721,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/3521\/revisions\/3721"}],"wp:attachment":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/media?parent=3521"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/categories?post=3521"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/tags?post=3521"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}